Intarcia Therapeutics

Discussion in 'Intarcia Therapeutics' started by anonymous, Mar 31, 2017 at 10:22 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    You have to see who is left, kinda of a circus...
     

  2. anonymous

    anonymous Guest

    Dude if you want to stay just practice saying "Yes Kurt" "Oh brilliant idea Kurt" "You are a genius Kurt" "Do you want me to hum and swallow ?"
     
  3. anonymous

    anonymous Guest

     
  4. anonymous

    anonymous Guest

    Yup, same circus. Don't know how things will continue forward if the same circus performers were retained.
     
  5. anonymous

    anonymous Guest

    Black Monday but y'all should've seen it coming and left the shit show 2+ years ago. Sadly, your CVs will be deleted as having Intarcia on a resume is the modern-day Scarlett letter as you were part of the "system" that got 2 CRLs in a row for the same generic drug in a 25 yr old worthless device.

    Alas, is the circus ringmaster still KG? No doubt the ass lickers survived the massive RIF.
     
  6. anonymous

    anonymous Guest

    Dudes and Dudettes, think this through. The key gateway and only hope for a blockbuster launch was direct sell to systems, IDNs and Payer/Provider hybrids that actually gave a shit about compliance. Now you have your market segment in no see lock down, and a Tx modality requiring a face to face incision and insertion with a HC provider.

    THIS IS DOOMED FOR AT LEAST 18 MONTHS MINIMUM!
     
  7. anonymous

    anonymous Guest

    Nah, "things" whatchamacallit will finally get done to this shit circus starting with Chap 11 BK filing with consultant leeches and 70% deadwoods taken out. Feel the burn!
     
  8. anonymous

    anonymous Guest

    People talking about another Rif june/july

    maybe that’s the other 30%left
     
  9. anonymous

    anonymous Guest

    Nothing to see here just a genius unicorn !!

    MAC Clauses. In an effort to protect lenders, venture loans may include a material adverse change (“MAC”) provision. The MAC clause allows lenders to cease lending, call the balance of the loan or restructure the loan should the lender believe the overall prospects of the company have worsened. The inclusion of a MAC clause underlies the notion that venture loans are designed for companies that have some track record of venture capital investment, a strong customer base and confidence in future growth.

    So if you have a loan and the FDA REJECTS YOU TWICE

    oh yeah the lender says "We you Mac Daddy bitch" "Wheres the Money Punk"
     
  10. anonymous

    anonymous Guest

    That sounds about right. File Chap 11 reorg BK now to seek some reliefs and Chap 7 liquidation BK by end of Q2.

    InFARTcia is indeed the biggest joke in the industry and many of us who ran into the arrogant dicks at ADA are ROFL.
     
  11. anonymous

    anonymous Guest

    Yes the employees should prepare for "execution"

    But while other biotechs at earlier stages of clinical development are choosing to float in record numbers to catch a wave of investor enthusiasm for the sector, Chief Executive Kurt Graves says being private suits him just fine.

    “We could go public right now if we wanted but strategically and operationally it is best to stay private for now because we are well-financed and having a laser focus on execution when you are getting ready to launch a diabetes drug is a big benefit,” he said in an interview.

    Please line up by the Pelaton and simply step out of the window... next....next....
     
  12. anonymous

    anonymous Guest

    The RIF is effective so those that are lucky to have been dismissed are gone by June. Can't imagine how much longer the remaining people would last after.
     
  13. anonymous

    anonymous Guest

    Y'all, bend over with pants down and lube of your choice as part of a pitiful severance package with the promise not to sue. :mad:
     
  14. anonymous

    anonymous Guest

    "Intarcia remains focused on building an innovative and important company in the chronic disease space – one dedicated to addressing serious unmet needs by disrupting the shortcomings of the pill and injection model in chronic disease management," said Kurt Graves, Chairman, President and CEO of Intarcia

    Those idiots at Novo - getting FDA approval for Oral GLP-1. That's Stupid. Only Intarcia has the GENIUS to gather FDA Rejection after FDA Rejection. Nobody has EVER built a Company around Rejection - Truely Disruptive

    Time2Disrupt
     
  15. anonymous

    anonymous Guest

    Yes Kurt just like you said.. I called the FDA like you wanted. When I said Intarcia they hung up.
     
  16. anonymous

    anonymous Guest

    Yep and said stay away, for good, assholes cuz y'all are full of shit!
     
  17. anonymous

    anonymous Guest

    ROFL - Bryan did you mean "demise of this GLP-1 programs" cuz that great leadership just f*cked you in the ass. Come on "proven we can make at scale" - who tha f*ck told you that bullshit ?? WTF "showing superiority" no CV benefit dumb shit

    Bryan Roberts, a partner with Venrock Associates who invested in Intarcia, gave a list of four bullet points when asked what convinced him to make such a big new investment. Here’s what he said:

    1. Great leadership in Kurt Graves

    2. Great 48-week data on a drug/device combo we have proven we can make at scale

    3. Demise of lots of other GLP-1 programs

    4
    . Phase 3 clinical development strategy that has a very high likelihood of showing superiority over other therapies in a huge market.
     
  18. anonymous

    anonymous Guest

    He has to be great, an average leader would have been fired after the first FDA failure. Only great ones fail twice and keep their paycheck

    it’s just a question of great at what
     
  19. anonymous

    anonymous Guest

    KG rules of losership

    1) anything that has worked anywhere - say KG did it
    2) all the KG shit that blows up blame everyone else
    3) assassinate anyone with talent they might look better that KG
    4) surround yourself with asslickers
     
  20. anonymous

    anonymous Guest



    Yes, being private allows them to continue to evade the public scrutiny that would reveal the depth of the fraud.